Be a Smart Investor
Thursday, July 13, 2017
Sale process for biotech Tesaro seen unlikely to result in deal
Biotech company Tesaro's sale process is unlikely to result in a deal, sources familiar with the situation told CNBC.
from Mergers and Acquisitions http://ift.tt/2timbnT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment